RSV Diagnostics Market - Growth Strategy Adopted by Top Players | Industry Report 2022

20.09.2019 - 14:51 | 1755348

Artikel von MarketsandMarkets™ INC.

According to the new market research report RSV Diagnostics Market is expected to reach USD 929.2 Million by 2022

According to the new market research report RSV Diagnostics Market is expected to reach USD 929.2 Million by 2022 from USD 574.3 Million in 2017, at a CAGR of 10.1%. Factors driving the growth of this market include the rising burden of RSV infections, growing demand for PoC molecular diagnostic tests for the diagnosis of RSV infections, and increasing approval of RSV diagnostic kits and assays.

Download Brochure:

The RSV diagnostics market is consolidated in nature due to the presence of a large number of players. The key players in the market are bioMerieux (France), Becton Dickinson (US), Abbott (US), Roche (Switzerland), Danaher (US), Thermo Fisher (US), Luminex (US), BioCartis (Belgium), Hologic (US), and Fast Track Diagnostics (Luxembourg).

Most companies in the RSV diagnostics market adopted agreements, expansions, and product launches as the key business growth strategy. These strategies accounted for the largest share of the overall growth strategies mapped from 2014 to 2017. Some of the leading players who adopted these strategies include bioMerieux (France), Abbott (US), Roche (Switzerland). bioMérieux is a world leader in in vitro diagnostics, molecular diagnostics, and microbiology automation. The company operates through two major business divisions, namely, clinical diagnostics and industrial microbiology.

The company provides healthcare solutions, such as clinical and sepsis solutions; industrial solutions, including food, biopharma, cosmetics and personal care, blood banks, and veterinary solutions; and total service solutions in the areas of laboratory workflow efficiency. It offers RSV diagnostic products through its clinical diagnostics division. The company focuses on product launches and acquisitions to enhance its presence in the market. For instance, bioMérieux commercialized its FilmArray multiplex PCR system in 2015. The company also adopts inorganic growth strategies to strengthen its position in the market. For instance, the company acquired BioFire Diagnostics (US) in 2014.

Abbott discovers, develops, manufactures, and markets nutritional, diagnostic, pharmaceutical, and vascular and diagnostic products. The company operates through four segments—Established Pharmaceuticals, Nutritionals, Diagnostics, and Vascular Products. Abbott Diagnostics offers a wide range of immunoassays and molecular diagnostic products in a range of automation and point of care devices. The company adopts inorganic and organic growth strategies in order to strengthen its position in the market. For instance, in 2016, the company received the US FDA and CLIA waivers for its Alere i RSV Rapid Molecular Test and Alere Reader Lateral Flow Assay Analyzer. Similarly, in 2017, the company acquired Alere Medical (US). Also in 2016, the company opened its diagnostics manufacturing facility in India.

Get Report Sample Pages:

Roche provides in vitro diagnostic products and drugs for cancer and transplantation. The company provides medicines for oncology, virology, inflammation, metabolism, CNS, clinical chemistry, immunology, urinalysis, blood screening, genetics, infectious diseases, and microbiology. Roche Molecular Diagnostics is a pioneer in in vitro diagnostics and personalized healthcare and offers a vast product portfolio in the fields of oncology, virology, blood screening, HPV, CT/NG, genomics, and microbiology. The company also offers RSV diagnostic products through its Diagnostics division. The company mainly focuses on organic strategies in order to strengthen its position in the market. For instance, in 2017, the company launched the cobas Liat PCR System and RSV Assays.

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441

Unternehmensinformation / Kurzprofil:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


PresseKontakt / Agentur:



Vor- / Nachname: MarketsandMarkets™ INC.


Keywords (optional):

Dieser Artikel wurde bisher 43 mal aufgerufen.


Direkter Link zu diesem Artikel:

Diese Pressemeldung bookmarken bei...

Tausendreporter BlinkList Folkd Furl Google Linkarena Mister Wong oneview Yahoo MyWeb YiGG Webnews Technorati

Über einen Link auf Ihrer News-, Presse- oder Partner-Seite würden wir uns sehr freuen.

Hiermit versichert der Erfasser, dass der eingestellte Artikel der Wahrheit entspricht. Er ist frei von Rechten Dritter und steht zur Veröffentlichung bereit. Die Haftung für eventuelle Folgen (z.B. Abmahnungen, Schadenersatzforderungen etc.) übernimmt der Eintrager und nicht

[ Anfrage per Mail | Fehlerhaften Artikel melden | Druckbare Version | Diesen Artikel an einen Freund senden ]

Alle Artikel von MarketsandMarkets™ INC. RSS Feed

Ambulatory EHR Market - Top Players and Global Forecast 2021
ESMO-Kongress 2019: Die Versorgung von Krebspatienten verbessern
Nie wieder Schweißgeruch - das ist nun möglich!
Emerging Economies Offer Lucrative Growth Opportunities for HIV Diagnosis
Schnelle Antworten dank Online Chat / ilapo reagiert noch effektiver auf Kundenanfragen

Blogverzeichnis - Blog Verzeichnis bloggerei.deBlog Top Liste - by